InsiderTrades

Form 4 for XENE Xenon Pharmaceuticals Inc.

Accepted 2024-03-11 00:00:00 ET · period of report 2024-03-08 · accession 0000950170-24-029542 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-03-11 2024-03-08 XENE GAROFALO ELIZABETH A. Dir M - OptEx $18.56 +3,500 3,500 New +$65.0K
D 2024-03-11 2024-03-08 XENE GAROFALO ELIZABETH A. Dir S - Sale+OE $45.69 -2,092 0 -100% -$95.6K
D 2024-03-11 2024-03-08 XENE GAROFALO ELIZABETH A. Dir F - Tax $46.16 -1,408 2,092 -40% -$65.0K
D 2024-03-11 2024-03-08 XENE GAROFALO ELIZABETH A. Dir M - OptEx $0.00 -3,500 16.5K -18% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Shares 2024-03-08 M A 3,500 $18.56 3,500 D — —
2 Common Common Shares 2024-03-08 S D 2,092 $45.69 0 D — —
3 Common Common Shares 2024-03-08 F D 1,408 $46.16 2,092 D — — (F1) Represents the closing price of the Company's common shares on March 7, 2024 for purposes of net settlement calculations.
4 Derivative Stock Option (Right to Buy) 2024-03-08 M D 3,500 $0.00 16,500 D $18.56 · — to 2031-06-02 20,000 Common Shares (F2) One-third of the total shares subject to the Option vested on the one year anniversary of the grant date, one-third of the total shares subject to the Option vested on the two year anniversary of the grant date, and one-third of the total shares subject to the Option shall vest on the three year anniversary of the grant date.